Can-Fite BioPharma says a patient has lived ten years cancer-free after using Namodenoson.

Nov 11, 2026, 2:03 AM ETTrialRead the original at globenewswire.com

Good for CANF

Can-Fite reported 1 patient stayed cancer-free for 10 years after a complete response. This supports Namodenoson's promise, but 1 patient's result cannot show how it works for others.

CANF · Can-Fite BioPharma

AI read · Good for CANF

The AI's read

That long-lasting response gives Can-Fite a hopeful example as it tests Namodenoson in a larger Phase III study for advanced liver cancer. But the report covers 1 patient from a completed Phase II study, so it cannot show whether other patients will have the same result.

Get alerts for CANF

Follow Can-Fite BioPharma (CANF) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for CANF

Free on the App Store and Google Play, or on the web.